MTHFR 677T is a strong determinant of the degree of hearing loss among Polish males with postlingual sensorineural hearing impairment.

DNA and cell biology 20120701

N-propionyl-4-S-cysteaminylphenol induces apoptosis in B16F1 cells and mediates tumor-specific T-cell immune responses in a mouse melanoma model.

Journal of dermatological science 20120701

Disulfide- and terminal alkyne-functionalized magnetic silica particles for enrichment of azido glycopeptides.

Chemical communications (Cambridge, England) 20120614

Utilization of the ferrous sulfate (Fricke) dosimeter for evaluating the radioprotective potential of cystamine: experiment and Monte Carlo simulation.

Radiation research 20120601

Identification of the oxidation products of cysteamine and cystamine by CE-MS interfaced by a noncommercial electrospray ionization source.

Journal of separation science 20120601

Functional properties and biodistribution of poly(triethylenetetramine/cystamine bisacrylamide) and poly(triethylenetetramine/cystamine bisacrylamide)- poly(ethylene glycol) mixtures formed with nucleic acid.

Journal of controlled release : official journal of the Controlled Release Society 20120410

pH- and redox-responsive polysaccharide-based microcapsules with autofluorescence for biomedical applications.

Chemistry (Weinheim an der Bergstrasse, Germany) 20120312

Colloidal stability of gold nanoparticles modified with thiol compounds: bioconjugation and application in cancer cell imaging.

Langmuir : the ACS journal of surfaces and colloids 20120306

Preparation of cystamine core dendrimer and antibody-dendrimer conjugates for MRI angiography.

Molecular pharmaceutics 20120305

Cystamine-tacrine dimer: a new multi-target-directed ligand as potential therapeutic agent for Alzheimer's disease treatment.

Neuropharmacology 20120201

Measuring the kinetics of amyloid fibril elongation using quartz crystal microbalances.

Methods in molecular biology (Clifton, N.J.) 20120101

A novel serum metabolomics-based diagnostic approach for colorectal cancer.

PloS one 20120101

Cystamine and ethyl-eicosapentaenoic acid treatment fail to prevent malonate-induced striatal toxicity in mice.

Neurobiology of aging 20111201

Novel participation of transglutaminase-2 through c-Jun N-terminal kinase activation in sphingosylphosphorylcholine-induced keratin reorganization of PANC-1 cells.

Biochimica et biophysica acta 20111201

Novel reduction-sensitive micelles for triggered intracellular drug release.

Journal of controlled release : official journal of the Controlled Release Society 20111010

Therapeutic advances in the management of Huntington's disease.

The Yale journal of biology and medicine 20110901

Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery.

Biomaterials 20110801

Superabsorbent polysaccharide hydrogels based on pullulan derivate as antibacterial release wound dressing.

Journal of biomedical materials research. Part A 20110701

Synthesis and in vitro evaluation of novel pro-drugs for the treatment of nephropathic cystinosis.

Bioorganic & medicinal chemistry 20110601

Folate pro-drug of cystamine as an enhanced treatment for nephropathic cystinosis.

Bioorganic & medicinal chemistry letters 20110415

Stimuli response of cystamine-core dendrimer revealed by diffusion and NOE NMR studies.

The journal of physical chemistry. B 20110414

Inhibition of tissue transglutaminase 2 attenuates contractility of pregnant human myometrium.

Biology of reproduction 20110401

Potential of cystamine and cysteamine in the treatment of neurodegenerative diseases.

Progress in neuro-psychopharmacology & biological psychiatry 20110330

Beneficial effects of treatment with transglutaminase inhibitor cystamine on the severity of inflammation in a rat model of inflammatory bowel disease.

Laboratory investigation; a journal of technical methods and pathology 20110301

Immobilization of selenocystamine on TiO2 surfaces for in situ catalytic generation of nitric oxide and potential application in intravascular stents.

Biomaterials 20110201

Rational design of a selective covalent modifier of G protein βγ subunits.

Molecular pharmacology 20110101

PEGylated derivatives of cystamine as enhanced treatments for nephropathic cystinosis.

Bioorganic & medicinal chemistry letters 20110101

TNF-alpha mediated NF-kappaB activation is constantly extended by transglutaminase 2.

Frontiers in bioscience (Elite edition) 20110101

Acyl cystamine: small-molecular foldase mimics accelerating oxidative refolding of disulfide-containing proteins.

Biotechnology progress 20110101

Bcr is a substrate for Transglutaminase 2 cross-linking activity.

BMC biochemistry 20110101

[Radioprotective properties of indralin combined with cystamine and mexamine].

Radiatsionnaia biologiia, radioecologiia 20110101

Effect of cystamine on blood pressure and vascular characteristics in spontaneously hypertensive rats.

Journal of vascular research 20110101

A nanostructured piezoelectric immunosensor for detection of human cardiac troponin T.

Sensors (Basel, Switzerland) 20110101

Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.

The Prostate 20101101

Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis.

Bioorganic & medicinal chemistry letters 20101101

Cystamine and intrabody co-treatment confers additional benefits in a fly model of Huntington's disease.

Neurobiology of disease 20101001

Activation of transglutaminase type 2 for aortic wall protection in a rat abdominal aortic aneurysm formation.

Journal of vascular surgery 20101001

Selenium and sulfur in exchange reactions: a comparative study.

The Journal of organic chemistry 20101001

Surface attachment of protein fibrils via covalent modification strategies.

The journal of physical chemistry. B 20100902

Epoxy-amine synthesised hydrogel scaffolds for soft-tissue engineering.

Biomaterials 20100901

Cystamine metabolism and brain transport properties: clinical implications for neurodegenerative diseases.

Journal of neurochemistry 20100901

Melanoma-targeted chemo-thermo-immuno (CTI)-therapy using N-propionyl-4-S-cysteaminylphenol-magnetite nanoparticles elicits CTL response via heat shock protein-peptide complex release.

Cancer science 20100901

Defective CFTR induces aggresome formation and lung inflammation in cystic fibrosis through ROS-mediated autophagy inhibition.

Nature cell biology 20100901

I-kappaBalpha depletion by transglutaminase 2 and mu-calpain occurs in parallel with the ubiquitin-proteasome pathway.

Biochemical and biophysical research communications 20100820

Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20100801

Stability and biodistribution of a biodegradable macromolecular MRI contrast agent Gd-DTPA cystamine copolymers (GDCC) in rats.

Pharmaceutical research 20100701

Cystamine protects from 3-nitropropionic acid lesioning via induction of nf-e2 related factor 2 mediated transcription.

Experimental neurology 20100701

An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. 1985.

British journal of pharmacology 20100701

Cystamine suppresses polyalanine toxicity in a mouse model of oculopharyngeal muscular dystrophy.

Science translational medicine 20100602

Transglutaminase participates in the blockade of neurotransmitter release by tetanus toxin: evidence for a novel biological function.

Amino acids 20100601

Proteomic analysis for the anti-apoptotic effects of cystamine on apoptosis-prone macrophage.

Journal of cellular biochemistry 20100601

Cystamine prevents MPTP-induced toxicity in young adult mice via the up-regulation of the brain-derived neurotrophic factor.

Progress in neuro-psychopharmacology & biological psychiatry 20100201

Noninvasive evaluation of antiangiogenic effect in a mouse tumor model by DCE-MRI with Gd-DTPA cystamine copolymers.

Molecular pharmaceutics 20100201

Transglutaminase 2 expression levels regulate sensitivity to cystamine plus TRAIL-mediated apoptosis.

Cancer letters 20100128

Synthesis and evaluation of nanoglobule-cystamine-(Gd-DO3A), a biodegradable nanosized magnetic resonance contrast agent for dynamic contrast-enhanced magnetic resonance urography.

International journal of nanomedicine 20100101

Gastric acid hypersecretory states: recent insights and advances.

Current gastroenterology reports 20091201

A novel array-based assay of in situ tissue transglutaminase activity in human umbilical vein endothelial cells.

Analytical biochemistry 20091115

Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay.

Experimental eye research 20091101

Sulfur metabolism in AIDS: cystamine as an anti-HIV agent.

AIDS research and human retroviruses 20091101

Measurement of sulfur-containing compounds involved in the metabolism and transport of cysteamine and cystamine. Regional differences in cerebral metabolism.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20091015

Involvement of tissue transglutaminase in endothelin 1-induced hypertrophy in cultured neonatal rat cardiomyocytes.

Hypertension (Dallas, Tex. : 1979) 20091001

N-propionyl-cysteaminylphenol-magnetite conjugate (NPrCAP/M) is a nanoparticle for the targeted growth suppression of melanoma cells.

The Journal of investigative dermatology 20090901

Application of a biodegradable macromolecular contrast agent in dynamic contrast-enhanced MRI for assessing the efficacy of indocyanine green-enhanced photothermal cancer therapy.

Journal of magnetic resonance imaging : JMRI 20090801

Homocysteine-induced toxicity increases TG2 expression in Neuro2a cells.

Amino acids 20090401

Cystamine attenuates the expressions of NOS- and TLR-associated molecules in the brain of NZB/W F1 mice.

European journal of pharmacology 20090401

Expression of tissue-type transglutaminase (tTG) and the effect of tTG inhibitor on the hippocampal CA1 region after transient ischemia in gerbils.

Brain research 20090331

Myenteric neuronal loss in rats with experimental colitis: role of tissue transglutaminase-induced apoptosis.

Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 20090301

Degradable nanogels as a nanoreactor for growing silica colloids.

Langmuir : the ACS journal of surfaces and colloids 20090217

Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.

Cancer letters 20090118

Tissue-type transglutaminase and the effects of cystamine on intracerebral hemorrhage-induced brain edema and neurological deficits.

Brain research 20090116

Calculating CVD risk in older patients.

The Practitioner 20090101

Plasma homocysteine is adversely associated with glomerular filtration rate in asymptomatic black and white young adults: the Bogalusa heart study.

European journal of epidemiology 20090101

Growth inhibition of re-challenge B16 melanoma transplant by conjugates of melanogenesis substrate and magnetite nanoparticles as the basis for developing melanoma-targeted chemo-thermo-immunotherapy.

Journal of biomedicine & biotechnology 20090101

Tunable redox-responsive hybrid nanogated ensembles.

Journal of the American Chemical Society 20081105

Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex.

Journal of neurochemistry 20081101

The role of physical activity level and B-vitamin status on blood homocysteine levels.

Medicine and science in sports and exercise 20081101

A new synthesis of cystamine modified Eu3+ DOTAM-Gly-Phe-OH: a conjugation ready temperature sensitive MRI contrast agent.

Organic & biomolecular chemistry 20081007

Poly(amidoamine) conjugates with disulfide-linked cholesterol pendants self-assembling into redox-sensitive nanoparticles.

Biomacromolecules 20081001

Beneficial effects of treatment with cystamine on brain in NZB/W F1 mice.

European journal of pharmacology 20080904

Drastically decreased reactivity of thiols and disulfides complexed by cucurbit[6]uril.

Organic letters 20080904

Sensitivity enhancement by Au nanoparticles in surface plasmon resonance chemical sensors.

Journal of nanoscience and nanotechnology 20080901

Mouse vanin-1 is cytoprotective for islet beta cells and regulates the development of type 1 diabetes.

Diabetologia 20080701

Synthesis and swelling properties of novel pH-sensitive poly(aspartic acid) gels.

Acta biomaterialia 20080501

Transglutaminase 2 and NF-kappaB interplay during NGF-induced differentiation of neuroblastoma cells.

Brain research 20080501

Disulfide S-monoxides convert xanthine dehydrogenase into oxidase in rat liver cytosol more potently than their respective disulfides.

Biological & pharmaceutical bulletin 20080501

Pulse radiolysis studies on reactions of hydroxyl radicals with selenocystine derivatives.

The journal of physical chemistry. B 20080410

No association between global leukocyte DNA methylation and homocysteine levels in schizophrenia patients.

Schizophrenia research 20080401

Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice.

International immunopharmacology 20080401

Cystamine restores GSTA3 levels in Vanin-1 null mice.

Free radical biology & medicine 20080315

Therapeutic attenuation of mitochondrial dysfunction and oxidative stress in neurotoxin models of Parkinson's disease.

Biochimica et biophysica acta 20080301

Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice.

European journal of pharmacology 20080128

Cystamine prevents ischemia-reperfusion injury by inhibiting polyamination of RhoA.

Biochemical and biophysical research communications 20080118

[Protective action of radioprotectors and shielding against high-energy protons in experiments with rats].

Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20080101

Effect of disulfide-containing compounds on the Na+ transport in the frog skin.

Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20080101

The physiological role of the Gomori-positive glia: a new hypothesis.

Folia medica Cracoviensia 20080101

Studies on the reducing systems for plant and animal thioredoxin-independent methionine sulfoxide reductases B.

Biochemical and biophysical research communications 20070928

Ultrasensitive detection of enzymatic activity with nanowire electrodes.

Journal of the American Chemical Society 20070919

[Long-term follow-up of ofloxacin-combined therapy for leprosy patients].

Nihon Hansenbyo Gakkai zasshi = Japanese journal of leprosy : official organ of the Japanese Leprosy Association 20070901

Cystamine ameliorates liver fibrosis induced by carbon tetrachloride via inhibition of tissue transglutaminase.

World journal of gastroenterology 20070828

Differential gene expression in mouse liver associated with the hepatoprotective effect of clofibrate.

Toxicology and applied pharmacology 20070715

The construction of 3D-engineered tissues composed of cells and extracellular matrices by hydrogel template approach.

Biomaterials 20070601

RGD targeted poly(L-glutamic acid)-cystamine-(Gd-DO3A) conjugate for detecting angiogenesis biomarker alpha(v) beta3 integrin with MRT, mapping.

International journal of nanomedicine 20070601

Stable supply of large amounts of human Fab from the inclusion bodies in E. coli.

Journal of biochemistry 20070501

Osteopontin promotes pathologic mineralization in articular cartilage.

Matrix biology : journal of the International Society for Matrix Biology 20070301

Beneficial effects of treatment with transglutaminase inhibitor cystamine on macrophage response in NZB/W F1 mice.

Experimental biology and medicine (Maywood, N.J.) 20070201

Methylenetetrahydrofolate reductase gene polymorphism and its association with coronary artery disease.

Sao Paulo medical journal = Revista paulista de medicina 20070104

Chronic cystamine treatment inhibits small artery remodelling in rats.

Journal of vascular research 20070101

[Comparative protective action of radiorotectors and shielding in gamma-irradiated mice].

Aviakosmicheskaia i ekologicheskaia meditsina = Aerospace and environmental medicine 20070101

Oxidation of glutathione and superoxide generation by inorganic and organic selenium compounds.

BioFactors (Oxford, England) 20070101

ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's disease.

Proceedings of the National Academy of Sciences of the United States of America 20061212

Hyperhomocysteinemia and low plasma folate as risk factors for central retinal vein occlusion: a case-control study in a Chinese population.

Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie 20061001

Leishmania species: evidence for transglutaminase activity and its role in parasite proliferation.

Experimental parasitology 20061001

Complex formation between tissue transglutaminase II (tTG) and vascular endothelial growth factor receptor 2 (VEGFR-2): proposed mechanism for modulation of endothelial cell response to VEGF.

Experimental cell research 20061001

Biodegradable cystamine spacer facilitates the clearance of Gd(III) chelates in poly(glutamic acid) Gd-DO3A conjugates for contrast-enhanced MR imaging.

Magnetic resonance imaging 20060901

The protective effects of cystamine in the R6/2 Huntington's disease mouse involve mechanisms other than the inhibition of tissue transglutaminase.

Neurobiology of aging 20060601

Neuroprotective effects of cystamine in aged parkinsonian mice.

Neurobiology of aging 20060601

Drug shows potential for treatment of Huntington's disease.

The Lancet. Neurology 20060601

Cystamine and cysteamine increase brain levels of BDNF in Huntington disease via HSJ1b and transglutaminase.

The Journal of clinical investigation 20060501

Cystamine and cysteamine prevent 3-NP-induced mitochondrial depolarization of Huntington's disease knock-in striatal cells.

The European journal of neuroscience 20060401

Stepwise assembly of acceptor--sigma spacer--donor monolayers: preparation and electrochemical characterization.

Langmuir : the ACS journal of surfaces and colloids 20060328

Mechanistic insight provided by glutaredoxin within a fusion to redox-sensitive yellow fluorescent protein.

Biochemistry 20060221

Contrast-enhanced magnetic resonance angiography with biodegradable (Gd-DTPA)-cystamine copolymers: comparison with MS-325 in a swine model.

Molecular pharmaceutics 20060101

A novel small molecule CFTR inhibitor attenuates HCO3- secretion and duodenal ulcer formation in rats.

American journal of physiology. Gastrointestinal and liver physiology 20051001

Cystamine treatment is neuroprotective in the YAC128 mouse model of Huntington disease.

Journal of neurochemistry 20051001

Phenoxybenzamine and benextramine, but not 4-diphenylacetoxy-N-[2-chloroethyl]piperidine hydrochloride, display irreversible noncompetitive antagonism at G protein-coupled receptors.

The Journal of pharmacology and experimental therapeutics 20050801

Treatment of YAC128 mice and their wild-type littermates with cystamine does not lead to its accumulation in plasma or brain: implications for the treatment of Huntington disease.

Journal of neurochemistry 20050801

A general fluorescence-based coupled assay for S-adenosylmethionine-dependent methyltransferases.

Biochemical and biophysical research communications 20050527

Post-translational disulfide modifications in cell signaling--role of inter-protein, intra-protein, S-glutathionyl, and S-cysteaminyl disulfide modifications in signal transmission.

Free radical research 20050501

Cerebral PET imaging and histological evidence of transglutaminase inhibitor cystamine induced neuroprotection in transgenic R6/2 mouse model of Huntington's disease.

Journal of the neurological sciences 20050415

Pharmacokinetics and tissue retention of (Gd-DTPA)-cystamine copolymers, a biodegradable macromolecular magnetic resonance imaging contrast agent.

Pharmaceutical research 20050401

Mechanism for the inhibition of transglutaminase 2 by cystamine.

Biochemical pharmacology 20050315

Small artery remodeling depends on tissue-type transglutaminase.

Circulation research 20050107

Mutant huntingtin protein: a substrate for transglutaminase 1, 2, and 3.

Journal of neuropathology and experimental neurology 20050101

Poly(ethylene oxide)-b-poly(N-isopropylacrylamide) nanoparticles with cross-linked cores as drug carriers.

Journal of biomaterials science. Polymer edition 20050101

Different inhibition characteristics of intracellular transglutaminase activity by cystamine and cysteamine.

Experimental & molecular medicine 20041231

Isolation and functional characterization of a cyst(e)amine-sensitive protein protecting methyl-dithio groups.

Biochimie 20041201

Cell-based assay for monitoring transglutaminase activity.

Analytical biochemistry 20041015

Production of dromedary (Camelus dromedarius) embryos by IVM and IVF and co-culture with oviductal or granulosa cells.

Theriogenology 20041001

Cystamine increases L-cysteine levels in Huntington's disease transgenic mouse brain and in a PC12 model of polyglutamine aggregation.

Journal of neurochemistry 20041001

Arabidopsis thaliana glutamate-cysteine ligase: functional properties, kinetic mechanism, and regulation of activity.

The Journal of biological chemistry 20040806

Vanin-1-/- mice exhibit a glutathione-mediated tissue resistance to oxidative stress.

Molecular and cellular biology 20040801

Dependence of Giardia lamblia encystation on novel transglutaminase activity.

Molecular and biochemical parasitology 20040801

Separation of organoselenium compounds and their electrochemical detection.

Analytical and bioanalytical chemistry 20040701

Synthesis, structure and electrochemistry of ferrocene-peptide macrocycles.

Dalton transactions (Cambridge, England : 2003) 20040607

A new fluorescence resonance energy transfer approach demonstrates that the histone variant H2AZ stabilizes the histone octamer within the nucleosome.

The Journal of biological chemistry 20040604

Tissue transglutaminase has intrinsic kinase activity: identification of transglutaminase 2 as an insulin-like growth factor-binding protein-3 kinase.

The Journal of biological chemistry 20040604

Transglutaminases - possible drug targets in human diseases.

Current drug targets. CNS and neurological disorders 20040401

Protective role of tissue transglutaminase in the cell death induced by TNF-alpha in SH-SY5Y neuroblastoma cells.

Journal of biochemistry and molecular biology 20040331

Pigment-lightening effect of N,N'-dilinoleylcystamine on human melanoma cells.

The British journal of dermatology 20040101

Radioprotective effects of amifostine (WR-2721) or cystamine on radiation damage and its repair in rats whole body exposed to fission neutrons.

Acta medica (Hradec Kralove) 20040101

Induction of the mitochondrial permeability transition by selenium compounds mediated by oxidation of the protein thiol groups and generation of the superoxide.

Biochemical pharmacology 20031215

Replacement therapy for vitamin B12 deficiency: comparison between the sublingual and oral route.

British journal of clinical pharmacology 20031201

Cystamine inhibits transglutaminase and caspase-3 cleavage in glutamate-exposed astroglial cells.

Journal of neuroscience research 20031001

Effects of monoamines formed in the cecum of horses on equine digital blood vessels and platelets.

American journal of veterinary research 20030901

Transglutaminase potentiates ligand-dependent proteasome dysfunction induced by polyglutamine-expanded androgen receptor.

Human molecular genetics 20030701

Cystamine inhibits caspase activity. Implications for the treatment of polyglutamine disorders.

The Journal of biological chemistry 20030207

[Comparative study of radioprotective efficiency of various doses of cystamine dissolved in normal saline solution or distilled water].

Radiatsionnaia biologiia, radioecologiia 20030101

In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.

Pediatric pathology & molecular medicine 20030101

Ferrocenoyl glycylcystamine: organization into a supramolecular helicate structure.

Chemical communications (Cambridge, England) 20021021

Therapeutic effects of cystamine in a murine model of Huntington's disease.

The Journal of neuroscience : the official journal of the Society for Neuroscience 20021015

High-performance liquid chromatographic method to quantify total cysteine excretion in urine.

Analytical biochemistry 20020801

Transglutaminase activity of human ER-60.

Bioscience, biotechnology, and biochemistry 20020601

Discrimination by SZL49 between contractions evoked by noradrenaline in longitudinal and circular muscle of human vas deferens.

British journal of pharmacology 20020501

Transglutaminase activity is involved in Saccharomyces cerevisiae wall construction.

Microbiology (Reading, England) 20020501

Electron transfer studies on self-assembled monolayers of helical ferrocenoyl-oligoproline-cystamine bound to gold.

Chemphyschem : a European journal of chemical physics and physical chemistry 20020415

Modulation of inflammatory paw oedema by cysteamine in the rat.

Pharmacological research 20020401

A piezoelectric immunoassay based on self-assembled monolayers of cystamine and polystyrene sulfonate for determination of Schistosoma japonicum antibodies.

Analytical and bioanalytical chemistry 20020401

Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine.

Nature medicine 20020201

Drosophila melanogaster glutamate-cysteine ligase activity is regulated by a modifier subunit with a mechanism of action similar to that of the mammalian form.

The Journal of biological chemistry 20020111

The ability of cystamine to bind DNA.

Amino acids 20020101

[Viability of lyophilized cells of Myxococcus xanthus UKM 10041 and Polyangium cellulosum UKM 10043 in presence of different antioxidants].

Mikrobiolohichnyi zhurnal (Kiev, Ukraine : 1993) 20020101

Comparison of different protein immobilization methods on quartz crystal microbalance surface in flow injection immunoassay.

Analytical biochemistry 20011215

The role of tissue transglutaminase in the germinal vesicle breakdown of mouse oocytes.

Biochemical and biophysical research communications 20010817

Catalytic selenols couple the redox cycles of metallothionein and glutathione.

European journal of biochemistry 20010601

T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminase.

European journal of immunology 20010501

Palladium-mediated C5 substitution of pyrimidine nucleosides.

Current protocols in nucleic acid chemistry 20010501

Electroanalytical applications of cationic self-assembled monolayers: square-wave voltammetric determination of dopamine and ascorbate.

Bioelectrochemistry (Amsterdam, Netherlands) 20010301

Inhibition of acetyl-CoA carboxylase by cystamine may mediate the hypotriglyceridemic activity of pantethine.

Medical hypotheses 20010301

Analogues of prazosin that bear a benextramine-related polyamine backbone exhibit different antagonism toward alpha1-adrenoreceptor subtypes.

Journal of medicinal chemistry 20010201

Phentolamine inhibits exocytosis of glucagon by Gi2 protein-dependent activation of calcineurin in rat pancreatic alpha -cells.

The Journal of biological chemistry 20010112

Effects of diallyl disulfide and other donors of sulfane sulfur on the proliferation of human hepatoma cell line (HepG2).

Neoplasma 20010101

Transglutaminase participates in the incorporation of latent TGFbeta into the extracellular matrix of aging articular chondrocytes.

Connective tissue research 20010101

The proteolytic activity and cleavage specificity of fibronectin-gelatinase and fibronectin-lamininase.

Journal of protein chemistry 19990501

Identification of transglutaminase-reactive residues in S100A11.

The Journal of biological chemistry 19980130

Zinc ejection as a new rationale for the use of cystamine and related disulfide-containing antiviral agents in the treatment of AIDS.

Journal of medicinal chemistry 19970620

Cystamine inhibits HIV type 1 replication in cells of monocyte/macrophage and T cell lineages.

AIDS research and human retroviruses 19950401

Cystamine potently suppresses in vitro HIV replication in acutely and chronically infected human cells.

The Journal of clinical investigation 19940501